In primary FSGS patients, we recently reported 54.7% of consecutive patients had IgM deposits on the sclerotic segments, and C3 deposits exclusively shown in those patients with IgM glomerular deposit. This evidence concerns the gene C3 and focal segmental glomerulosclerosis.